The involvement of ERRα in VEGF regulation has been documented in endothelial [26] and breast cancer cells [27,29]; however, our study is the first to show that inhibiting ERRα disrupts HIF-1α binding to the VEGF promoter in breast cancer cells. This evidence concerns the gene HIF1A and breast carcinoma.